Dr Joanne Davis
Honorary (Fellow)
Department of Medicine
50 Scholarly works
0 Projects
HIGHLIGHTS
2025
Journal article
Immunological responses to blinatumomab treatment in B-acute lymphoblastic leukaemia (B-ALL) patients - australasian leukemia and lymphoma group ALL08 blam study
DOI: 10.1182/blood-2025-33412025
Journal article
Post-Transplant Anti-Thymocyte Globulin (ATG) Exposure in Recipients of Reduced-Intensity Conditioning Transplantation Receiving ATG As Gvhd Prophylaxis Is Predictive of Gvhd, Relapse-Free Survival.
DOI: 10.1016/j.jtct.2025.01.4472024
Journal article
Marginal Zone Lymphoma Is Associated with Dysregulated Peripheral Blood Immunity Which Is Not Changed By Ibrutinib-Venetoclax Treatment
DOI: 10.1182/blood-2024-1998662024
Journal article
A phase 1 dose-escalation study of low-dose lenalidomide maintenance post-allogeneic stem cell transplantation for high-risk acute myeloid leukaemia or myelodysplastic syndrome
DOI: 10.1038/s41409-023-02195-x2024
Journal article
Modified cell trace violet proliferation assay preserves lymphocyte viability and allows spectral flow cytometry analysis
DOI: 10.1002/cyto.a.248302023
Journal article
A phase 1 clinical trial of the repurposable acetyllysine mimetic, n-methyl-2-pyrrolidone (NMP), in relapsed or refractory multiple myeloma
DOI: 10.1186/s13148-023-01427-72021
Journal article
Ibrutinib protects T cells in patients with CLL from proliferation-induced senescence
DOI: 10.1186/s12967-021-03136-2
RECENT SCHOLARLY WORKS
2021
Journal article
Venetoclax or Ruxolitinib in Pre-Transplant Conditioning Lowers the Engraftment Barrier by Different Mechanisms in Allogeneic Stem Cell Transplant Recipients
DOI: 10.3389/fimmu.2021.7490942020
Journal article
Immune recovery in patients with mantle cell lymphoma receiving long-term ibrutinib and venetoclax combination therapy
DOI: 10.1182/BLOODADVANCES.20200028102020
Conference Proceedings
Venetoclax or Ruxolitinib Depletion of Recipient NK Cells, in Combination with Reduced Intensity Conditioning, Improves Donor Cell Engraftment without Gvhd in a Mouse Model of Allosct.
DOI: 10.1016/j.bbmt.2019.12.033